Preventing or delaying the onset of end-stage kidney disease is vital. By implementing a results-driven, value-based approach, Dallas Nephrology Associates has demonstrated improved patient outcomes and value for payers.
Mollyn Shew
Advertisement
Articles by Mollyn Shew
Advertisement
Latest Updated Articles
Dallas Nephrology Associates’ Journey to Value-Based CareDecember 10th 2024
Advertisement
Advertisement
Trending on AJMC
1
5 Things to Know About the FDA's Peptide Reversal
2
Moderna, Merck mRNA Cancer Vaccine Succeeds in Late-Stage Trial
3
FDA Approves First Orexin Agonist for Narcolepsy Type 1
4
Student Mental Health, Success Tied to Future Health and Affordability
5